Recurrence of convexity meningiomas: Tumor cells in the arachnoid membrane

Surgical Neurology

Volumn 56, Issue 4, 2001, Pages 228-235

  Kamitani, Hiroshi ^a   Masuzawa, Hideaki ^a   Kanazawa, Itaru ^a   Kubo, Toshiro ^a  

^a Kanto Teishin Hospital   (Japan)

Author keywords

Arachnoid; Meningioma; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ARACHNOID; BRAIN SURGERY; CANCER RECURRENCE; CLINICAL ARTICLE; DURA MATER; FEMALE; HUMAN; HUMAN TISSUE; MALE; MENINGIOMA; RECURRENCE RISK; SURGICAL TECHNIQUE;

ADULT; AGED; ARACHNOID; FEMALE; HUMANS; MALE; MEMBRANES; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035191068     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(01)00582-1     Document Type: Article

References (32)

1. Prayson RA. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas; a study of 90 tumors
2. The recurrence of intracranial meningiomas after surgical treatment
3. Meningiomas
4. Recurring intracranial meningiomas; evaluation of some factors predisposing for tumor recurrence
5. Recurrence of intracranial meningiomas; the role played by regional multicentricity
6. Recurrence of intracranial meningiomas: the role played by regional multicentricity. Part 2; Clinical and radiological aspects
7. Prediction of recurrence in meningiomas after surgical treatment; a quantitative approach
8. Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma
9. Histopathologic features predicting recurrence of meningiomas following subtotal resection
10. The growth rate of intracranial meningiomas and its relation to histology
11. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis
12. Histological subtypes and prognostic problems in meningiomas
13. Grade zero removal of supratentorial convexity meningiomas
14. The significance of nuclear organizer region (AgNOR) score in predicting meningioma recurrence
15. Factors associated with survival in patients with meningioma
16. The prediction of recurrence in meningiomas. A flow cytometric study of paraffin-embedded archival material
17. Atypical and malignant meningiomas; a clinicopathological review
18. Intracranial meningiomas; analysis of recurrence after surgical treatment
19. DNA determination in the clinical management of patients with meningioma or hemangioblastoma
20. Meningioma; analysis of recurrence and progression following neurosurgical resection
21. MIB 1 staining index and scoring of histologic features in meningiomas. Indication for the prediction of biologic potential and postoperative management
22. Meningioma grading. An analysis of histologic parameters
23. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas
24. Characterization of nuclear DNA content, proliferation index, and nuclear size in a series 181 meningiomas, including benign primary, recurrent, and malignant tumors
25. The recurrence of intracranial meningiomas after surgical treatment
26. Primarily resected meningiomas; outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988
27. Correlation between cytogenetic and histopathological findings in 75 human meningiomas
28. Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C Schneider Lecture